Publikationen der ALS-Forschungsgruppe an der Charité
Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD
Münch C, Rosenbohm A, Sperfeld AD, Uttner I, Reske S, Krause BJ,
Frequency of a tau genotype in amyotrophic lateral sclerosis
Münch C, Prechter F, Xu R, Linke P, Prudlo J, Kuzma M,
Early-onset ALS with long-term survival associated with spastin gene mutation
Meyer T, Schwan A, Dullinger JS, Brocke J, Hoffmann KT, Nolte CH,
Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS
Münch C, Sedlmeier R, Meyer T, Homberg V, Sperfeld AD, Kurt A,
Chromosomal translocation t(18;21)(q23;q22.1) indicates novel susceptibility loci for frontotemporal dementia with ALS
Prudlo J, Alber B, Kalscheuer VM, Roemer K, Martin T, Dullinger J,
High rate of constitutional chromosomal rearrangements in apparently sporadic ALS
Meyer T, Alber B, Roemer K, Martin T, Kalscheuer VM, Göttert E,
Publikationen mit Beteiligung der ALS-Forschungsgruppe an der Charité
Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis
Fernández-Santiago R, Hoenig S, Lichtner P,
Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: report on the 142nd ENMC international workshop
Ludolph AC, Bendotti C, Blaugrund E,
Familial ALS in Germany: origin of the R115G SOD1 mutation by a founder effect
Niemann S, Joos H, Meyer T,
The role of excitotoxicity in ALS – what is the evidence?
Ludolph AC, Meyer T, Riepe MW.J
Antiglutamate therapy of ALS – which is the next step?
Ludolph AC, Meyer T, Riepe MW.J
Molecular biology findings in amyotrophic lateral sclerosis
Bachus R, Claus A, Meyer T,
